Drug Trial Radar · NCT07459647
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Mar 31, 2026
Primary completion
Feb 2030
Study completion Feb 2030
Sponsor
- Lead sponsor
- MapLight TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Mar 10, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
ML-007C-MA-212 is a 52-week open-label study designed to evaluate the long-term safety, tolerability, and effectiveness of ML-007C-MA in participants with schizophrenia who have recently completed an antecedent study (ML-007C-MA-211) or enroll directly (De Novo Cohort).
Conditions
- Schizophrenia
Interventions
ML-007C-MADrug
ML-007C-MA dosed as 210/3 mg BID
Primary outcomes
What the sponsor says the trial is designed to measure.
- To assess the safety and tolerability of long-term ML-007C-MA administration in adult participants with schizophreniaTime frame: From initial dose through end of treatment (up to 52 weeks)
Locations
45 sites in 1 country. Site status is shown where the registry gives one.
Clinical Site
Little Rock, Arkansas · Recruiting
Clinical Site
Little Rock, Arkansas · Recruiting
Clinical Site
Rogers, Arkansas · Recruiting
Clinical Site
Bellflower, California · Recruiting
Clinical Site
Cerritos, California · Recruiting
Clinical Site
Culver City, California · Recruiting
Clinical Site
Garden Grove, California · Recruiting
Clinical Site
Lemon Grove, California · Recruiting
Clinical Site
Long Beach, California · Recruiting
Clinical Site
Los Angeles, California · Recruiting
Clinical Site
Montclair, California · Recruiting
Clinical Site
Oceanside, California · Recruiting
Clinical Site
Orange, California · Recruiting
Clinical Site
Pico Rivera, California · Recruiting
Clinical Site
Riverside, California · Recruiting
Clinical Site
San Diego, California · Recruiting
Clinical Site
Sherman Oaks, California · Recruiting
Clinical Site
Torrance, California · Recruiting
Clinical Site
Hollywood, Florida · Recruiting
Clinical Site
Hollywood, Florida · Recruiting
Clinical Site
Miami, Florida · Recruiting
Clinical Site
Miami, Florida · Recruiting
Clinical Site
Miami Lakes, Florida · Recruiting
Clinical Site
West Palm Beach, Florida · Recruiting
Clinical Site
Atlanta, Georgia · Recruiting
Clinical Site
Decatur, Georgia · Recruiting
Clinical Site
Chicago, Illinois · Recruiting
Clinical Site
Gaithersburg, Maryland · Recruiting
Clinical Site
Boston, Massachusetts · Recruiting
Clinical Site
Watertown, Massachusetts · Recruiting
Clinical Site
Ann Arbor, Michigan · Recruiting
Clinical Site
Flowood, Mississippi · Recruiting
Clinical Site
Las Vegas, Nevada · Recruiting
Clinical Site
Marlton, New Jersey · Recruiting
Clinical Site
Cedarhurst, New York · Recruiting
Clinical Site
New York, New York · Recruiting
Clinical Site
Staten Island, New York · Recruiting
Clinical Site
The Bronx, New York · Recruiting
Clinical Site
North Canton, Ohio · Recruiting
Clinical Site
West Chester, Ohio · Recruiting
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.